Telix Quarterly Shareholder Update – CEO Presentation and Transcript of Investor Conference Call

Melbourne (Australia) – 22nd April 2020. Telix Pharmaceuticals releases Quarterly Shareholder Update and the transcript from today’s conference call with investors.

Telix Pharmaceuticals is pleased to provide its Quarterly Shareholder Update presentation and the transcript of CEO Dr Chris Behrenbruch’s conference call with investors.

To read the full transcript please click here.

To view the PowerPoint presentation please click here.

The Investor Call and Q&A was recorded and is now available for on-demand public viewing at: